Please try another search
VBI Vaccines Inc. (VBI) is a biopharmaceutical company. VBI develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. VBI is focused on targeting and overcoming infectious diseases, including hepatitis B, coronaviruses, and cytomegalovirus (CMV), as well as aggressive cancers including glioblastoma (GBM). The Company’s products include 3-antigen hepatitis B virus (HBV) Vaccine Candidate; VBI-2900, which is a coronavirus vaccine program (VBI-2901, VBI-2902, VBI-2905); VBI-1501, which is prophylactic CMV vaccine candidate; VBI-2601, which is HBV Immunotherapeutic Candidate, and VBI-1901 GBM. The Company is conducting the Phase I/IIa clinical study of GBM vaccine immunotherapeutic candidate VBI-1901. It is also conducting the Phase I clinical study of prophylactic COVID-19 vaccine candidate, VBI-2902 and clinical study with VBI-2905, COVID-19 vaccine candidate against the Beta variant.
Name | Age | Since | Title |
---|---|---|---|
Steven S. Gillis | 70 | 2016 | Independent Chairperson of the Board |
Jeffery R. Baxter | 62 | 2016 | President, CEO & Director |
Peter A. Patriarca | - | 2018 | Member of Scientific Advisory Board |
Nell Beattie | 35 | 2015 | CFO, Head of Corporate Development & Director |
Eddy A. Bresnitz | - | 2020 | Member of Commercial Advisory Board |
Blaine H. McKee | 58 | 2019 | Independent Director |
Daniel Shouval | - | 2018 | Member of Scientific Advisory Board |
Damian A. Braga | 67 | 2020 | Chairperson of the Commercial Advisory Board & Independent Director |
Nadia G. Tornieporth | - | 2018 | Member of Scientific & Clinical Advisory Board |
Stefan Thoelen | - | 2018 | Member of Scientific Advisory Board |
Allen Waziri | - | 2018 | Member of Scientific & Clinical Advisory Board |
Stanley A. Plotkin | 90 | - | Member of Scientific Advisory Board |
Michel De Wilde | 74 | 2016 | Independent Director and Chair of Scientific & Clinical Advisory Boards |
Patrick Yung Wen | - | 2018 | Member of Scientific & Clinical Advisory Board |
Pierre Van Damme | - | 2018 | Member of Scientific Advisory Board |
John D. Grabenstein | - | 2020 | Member of Commercial Advisory Board |
Denis R. Burger | 79 | - | Member of Scientific Advisory Board |
Michael D. Decker | - | 2020 | Member of Commercial Advisory Board |
Adam Finn | - | 2018 | Member of Scientific Advisory Board |
Robert Pass | - | 2018 | Member of Scientific Advisory Board |
Joanne Cordeiro | 65 | 2019 | Independent Director |
Michael Lim | - | 2018 | Member of Scientific & Clinical Advisory Board |
Bruce Smith | - | 2018 | Member of Scientific Advisory Board |
Vaughn B. Himes | 62 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review